Implantation of the sella turcica with 90-yttrium in the treatment of Cushing's syndrome of pituitary origin.
D015065:17-Hydroxycorticosteroids / Q000652:urine; D015068:17-Ketosteroids / Q000652:urine; D000293:Adolescent; D000328:Adult; D001786:Blood Glucose; D002118:Calcium / Q000652:urine; D002559:Cerebrospinal Fluid Rhinorrhea / Q000209:etiology; D003480:Cushing Syndrome / Q000209:etiology / Q000532:radiotherapy*; D003907:Dexamethasone; D003919:Diabetes Insipidus / Q000209:etiology; D005260:Female; D006066:Gonads / Q000503:physiopathology; D006801:Humans; D006964:Hyperpituitarism / Q000150:complications / Q000532:radiotherapy*; D008297:Male; D008590:Meningoencephalitis; D008875:Middle Aged; D010901:Pituitary Function Tests; D010910:Pituitary Irradiation / Q000009:adverse effects; D010913:Pituitary-Adrenal System / Q000528:radiation effects; D011379:Prognosis; D012658:Sella Turcica; D015020:Yttrium Isotopes / Q000009:adverse effects / Q000627:therapeutic use*
D015065:17-Hydroxycorticosteroids; D015068:17-Ketosteroids; D001786:Blood Glucose; D015020:Yttrium Isotopes; D003907:Dexamethasone; D002118:Calcium